Adriana Jimenez

Adriana Jimenez

Auto-generated profile, based on publicly available information

Adriana Jimenez

University of Miami Health System, Miami, Florida USA; Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2012 in American Journal of Infection Control
Verified
Journal Article
Closed access
LML. Silvia Munoz-Price
L. Silvia Munoz-Price
KAKristopher L. Arheart
Kristopher L. Arheart
JMJohn P. Mills
John P. Mills
TCTimothy Cleary
Timothy Cleary
DDDennise DePascale
Dennise DePascale
DLDavid A. Lubarsky
David A. Lubarsky

7 December 2016 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
AJAdriana Jiménez
Adriana Jiménez
JCJosé G. Castro
José G. Castro
LML. Silvia Munoz-Price
L. Silvia Munoz-Price
DPDennise de Pascale
Dennise de Pascale
LSLuis Shimose
Luis Shimose
YDYohei Doi
Yohei Doi
OBJECTIVE: To describe the investigation and control of a rare cluster ofKlebsiella pneumoniaecarbapenemase–producingCitrobacter freundiiin a hospital in southern Florida.METHODS: An epidemiologic investigation, review of infection prevention procedures, and molecular studies including whole genome sequencing were conducted.RESULTS: An outbreak ofK. pneumoniaecarbapenemase–3-producingC. freundiiwas identified at a tertiary hospital in Florida in 2014. Of the 6 cases identified, 3 occurred in the same intensive care unit and were caused by the same clone. For 2 of the 3 remaining cases, the isolates had low carbapenem minimum inhibitory concentrations and were unrelated by whole genome sequencing. As a response to the outbreak, supplementary environmental cleaning was implemented, including closure and terminal cleaning of the unit where the 3 cases clustered, in addition to the infection control bundle already in place at the time. No further cases were identified after these additional interventions.CONCLUSIONS: AlthoughC. freundiiis not a species that commonly demonstrates carbapenem resistance, our findings suggest that carbapenemase-producingC. freundiimay be underdetected even when active surveillance is in place and has a potential to cause hospital outbreak.Infect Control Hosp Epidemiol2017;38:320–326

1 May 2014 in American Journal of Infection Control
Verified
Journal Article
Closed access
LML. Silvia Munoz-Price
L. Silvia Munoz-Price
PCPhilip Carling
Philip Carling
TCTimothy Cleary
Timothy Cleary
YFYovanit Fajardo-Aquino
Yovanit Fajardo-Aquino
DDDennise DePascale
Dennise DePascale
KAKristopher Arheart
Kristopher Arheart

19 October 2018 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
LALilian Abbo
Lilian Abbo
BSBhavarth S Shukla
Bhavarth S Shukla
AGAmber Giles
Amber Giles
LALaura Aragon
Laura Aragon
AJAdriana Jimenez
Adriana Jimenez
CACesar A Arias
Cesar A Arias
Background: Vancomycin-resistant enterococci are an important cause of healthcare-associated infections and are inherently resistant to many commonly used antibiotics. Linezolid is the only drug currently approved by the US Food and Drug Administration to treat vancomycin-resistant enterococci; however, resistance to this antibiotic appears to be increasing. Although outbreaks of linezolid- and vancomycin-resistant Enterococcus faecium (LR-VRE) in solid organ transplant recipients remain uncommon, they represent a major challenge for infection control and hospital epidemiology.Methods: We describe a cluster of 4 LR-VRE infections among a group of liver and multivisceral transplant recipients in a single intensive care unit. Failure of treatment with linezolid in 2 cases led to a review of standard clinical laboratory methods for susceptibility determination. Testing by alternative methods including whole genome sequencing (WGS) and a comprehensive outbreak investigation including sampling of staff members and surfaces was performed.Results: Review of laboratory testing methods revealed a limitation in the VITEK 2 system with regard to reporting resistance to linezolid. Linezolid resistance in all cases was confirmed by E-test method. The use of WGS identified a resistant subpopulation with the G2376C mutation in the 23S ribosomal RNA. Sampling of staff members’ dominant hands as well as sampling of surfaces in the unit identified no contaminated sources for transmission.Conclusions: This cluster of LR-VRE in transplant recipients highlights the possible shortcomings of standard microbiology laboratory methods and underscores the importance of WGS to identify resistance mechanisms that can inform patient care, as well as infection control and antibiotic stewardship measures.

1 November 2020 in Emerging Infectious Diseases
Verified
Journal Article
Closed access
AJAdriana Jimenez
Adriana Jimenez
LALilian M. Abbo
Lilian M. Abbo
OMOctavio Martinez
Octavio Martinez
BSBhavarth Shukla
Bhavarth Shukla
KSKathleen Sposato
Kathleen Sposato
YDYohei Doi
Yohei Doi
We describe an outbreak caused by Serratia marcescens carrying blaKPC-3 that was sourced to a long-term care facility in Florida, USA. Whole-genome sequencing and plasmid profiling showed involvement of 3 clonal lineages of S. marcescens and 2 blaKPC-3-carrying plasmids. Determining the resistance mechanism is critical for timely implementation of infection control measures.

10 July 2025 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
LCLuisa Fernanda Lopez Cano
Luisa Fernanda Lopez Cano
SASebastian Arenas
Sebastian Arenas
AJAdriana Jimenez
Adriana Jimenez
TFTanira B D Ferreira
Tanira B D Ferreira
DPDipen J Parekh
Dipen J Parekh
DSD Joseph Sexton
D Joseph Sexton
Background: Candida auris colonization screening is often performed using bilateral axilla and groin composite swabs. However, re-screening results for the same patient are often inconsistent over time, complicating interpretation of results. To address this, we designed and evaluated screening using an anterior nares and hands composite collection strategy in a cohort of patients colonized with C. auris. Methods: This study included patients colonized with C. auris and cohorted on a 30-bed unit. Separate axilla and groin swabs, and anterior nares and hands swabs were obtained simultaneously at 6 different time points and tested by polymerase chain reaction (PCR) and culture. Results: A total of 102 swabs (51 of each composite swab type) from 19 patients were collected. By culture, 35 (69%) axilla and groin swabs were positive compared with 45 (88%) anterior nares and hands swabs. With PCR, 41 (80%) axilla and groin swabs and 50 (98%) anterior nares and hands swabs were positive. By culture, 15 temporal inconsistencies were observed with axilla and groin as compared with one instance with anterior nares and hands. With PCR, 12 temporal inconsistencies were observed with axilla and groin compared with 2 instances with the anterior nares and hands. Conclusions: We found more positives and consistent positivity for anterior nares and hands swabs by both culture and PCR, suggesting that these sources provide more reliable detection of C. auris colonization. Anterior nares and hands composite swabs provide an alternative screening approach for C. auris colonization screening that can improve test consistency.